Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2009 R21 RFA-CA-08-009 FOWLER, CAROL B AMERICAN REGISTRY OF PATHOLOGY, INC. RECOVERY OF PROTEINS FROM FORMALIN-FIXED TISSUES UNDER HIGH HYDROSTATIC PRESSURE Complete
2013 R33 RFA-CA-12-003 KAMM, ROGER D. MASSACHUSETTS INSTITUTE OF TECHNOLOGY MICROFLUIDIC 3D ASSAYS FOR METASTATIC CANCER Complete
2016 R43 PAR-13-327 GUNDERSON, KEVIN L ENCODIA, INC. Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer Complete
2000 R41 PAR-98-066 SKIPPER, PAUL L NEWTON SCIENTIFIC, INC. TRITIUM AMS ANALYSIS OF CANCER BIOMARKERS Complete
2002 R43 PAR-01-105 ISRAEL, BARBARA A. PLATYPUS TECHNOLOGIES, LLC OBLIQUELY DEPOSITED SUBSTRATES FOR DETECTION OF RAS Complete
2006 R21 RFA-CA-06-003 FRANKENBURG, SHOSHANA HADASSAH-HEBREW UNIVERSITY MEDICAL CTR TARGETED ANTIGEN DELIVERY FOR CANCER IMMUNOTHERAPY Complete
2006 R21 RFA-CA-06-003 MEYER, TOBIAS STANFORD UNIVERSITY DISSECTION OF THE MODULAR STRUCTURE OF CANCER SIGNALING SYSTEMS Complete
2009 R21 RFA-CA-08-006 LESSNICK, STEPHEN L. UNIVERSITY OF UTAH ANTIBODY-BASED DETECTION OF TRANSLOCATIONS IN PEDIATRIC CANCER Complete
2012 R21 RFA-CA-12-002 TAO, NONGJIAN ARIZONA STATE UNIVERSITY-TEMPE CAMPUS CHARGE SENSITIVE OPTICAL DETECTION FOR HIGH THROUGHPUT STUDY OF SMALL MOLECULES Complete
2016 R21 RFA-CA-15-002 BURGETT, ANTHONY WG UNIVERSITY OF OKLAHOMA NORMAN MASS SPECTROMETRY DETECTION OF DRUGS IN SINGLE BLADDER CANCER CELLS FROM PATIENTS Complete
2019 R21 RFA-CA-18-002 MONTAGNA, CRISTINA ALBERT EINSTEIN COLLEGE OF MEDICINE Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions Complete
2000 R21 PAR-99-100 MAJUMDAR, ARUNAVA UNIVERSITY OF CALIFORNIA BERKELEY OPTOMECHANICAL CHIPS FOR MOLECULAR PROFILING OF CANCER Complete
2002 R21 PAR-99-102 CHODOSH, LEWIS A UNIVERSITY OF PENNSYLVANIA TEMPORAL ANALYSIS OF MAMMARY CARCINOGENESIS Complete
2005 R21 RFA-CA-05-003 GREEN, ROLAND D NIMBLEGEN SYSTEMS, INC. MAPPING REGULATORY PATHWAYS IN CANCERS Complete
2008 R21 RFA-CA-07-035 KEELY, PATRICIA J UNIVERSITY OF WISCONSIN-MADISON USING NEW OPTICAL TECHNIQUES TO STUDY CELL SIGNALING IN 3D MATRICES Complete
2011 R21 RFA-CA-10-005 ZEICHNER, STEVEN L CHILDREN'S RESEARCH INSTITUTE DEVELOPMENT OF AN IN VIVO SCREENING TECHNOLOGY FOR CANCER VACCINE IMMUNOGENS Complete
2015 R21 RFA-CA-14-005 MITRAGOTRI, SAMIR S UNIVERSITY OF CALIFORNIA SANTA BARBARA ASSESSING THE RISK OF UV-INDUCED SKIN CANCER VIA NON-INVASIVE EPIDERMAL SAMPLING Complete
2018 R33 RFA-CA-17-011 LIU, YANG UNIVERSITY OF PITTSBURGH AT PITTSBURGH High-throughput super-resolution imaging of chromatin structures at different epigenetic states Complete
1999 R43 PAR-98-066 WEAVER, DANIEL C GENOMICA CORPORATION ANALYZING GENE EXPRESSION FOR CANCER GENE DISCOVERY Complete
2001 R43 PAR-99-101 WANG, JIWU ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INNOVATIVE RNA PROFILING IN CANCER CELLS Complete
2004 R43 PAR-01-105 NIELSEN, ULRIK B. MERRIMACK PHARMACEUTICALS, INC. PRODUCTION OF ANTIBODIES SUITABLE FOR MICROARRAYS Complete
2007 R33 RFA-CA-07-001 LIU, EDISON TAK-BUN GENOME INSTITUTE OF SINGAPORE PAIR-END-DITAG TECHNOLOGIES FOR THE COMPLETE ANNOTATION OF FUSION GENES Complete
2010 R21 RFA-CA-09-008 LIU, GUODONG NORTH DAKOTA STATE UNIVERSITY DEVELOPMENT OF A HAND-HELD CANCER BIOMARKER MONITOR Complete
2014 R33 RFA-CA-13-002 ROBINSON, WILLIAM H STANFORD UNIVERSITY LARGE-SCALE CHARACTERIZATION OF ANTI-CANCER ANTIBODY RESPONSES IN LUNG ADENOCARCI Complete
2017 R33 RFA-CA-16-004 PATTENDEN, SAMANTHA GAIL UNIV OF NORTH CAROLINA CHAPEL HILL The application of Enhanced Cavitation to enable DNA and Chromatin Extraction from Archived Tissues Complete
2021 R44 PAR-18-303 HUNG, PAUL JU-SUNG COMBINATI, INC. Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring Complete
2001 R33 PAR-98-067 SHACKNEY, STANLEY E ALLEGHENY-SINGER RESEARCH INSTITUTE MOLECULAR PROFILING OF CELLS BY LASER SCANNING CYTOMETRY Complete
2003 R33 PAR-01-106 RONINSON, IGOR B ORDWAY RESEARCH INSTITUTE, INC. FUNCTION-BASED SELECTION OF TARGET GENES IN TUMOR CELLS Complete
2007 R21 RFA-CA-07-001 DING, ZHIYONG UT MD ANDERSON CANCER CTR EFFECTIVE MAMMALIAN TWO HYBRID SCREENING APPROACH Complete
2009 R33 RFA-CA-08-008 BEEBE, DAVID J UNIVERSITY OF WISCONSIN-MADISON MICROCHANNEL CELL-BASED ASSAYS TO ENABLE CANCER RESEARCH Complete
2013 R33 RFA-CA-12-003 FURDUI, CRISTINA MARIA WAKE FOREST UNIVERSITY HEALTH SCIENCES NEW REAGENTS FOR TRACKING PROTEIN OXIDATION IN CELLS BY MS AND IMAGING METHODS Complete
2016 R43 PAR-13-327 LIM, MARK AMBERGEN, INC Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays Complete
2000 R41 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION MONOLITHIC MULTI-CAPILLARY ARRAYS TO SEQUENCE DNA Complete
2002 R43 PAR-01-105 BECKER, CHRISTOPHER SURROMED, INC. AFFINITY MASS TAGS FOR DIFFERENTIAL PHENOTYPING Complete
2000 R43 PAR-99-101 BUTT, TAUSEEF R. LIFESENSORS, INC. LIVESENSORS FOR MOLECULAR PROFILING IN PROSTATE CANCER Complete
2002 R43 PAR-01-105 STRAUME, TORE GENMETRIX, LLC ASSAY FOR DETECTION OF CANCER CHROMOSOME ABNORMALITIES Complete
2006 R21 RFA-CA-06-003 FERRARI, MAURO UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON NANOPARTICLES FOR HARVESTING AND TARGETING ANGIOGENIC PROTEINS Complete
2009 R21 RFA-CA-08-006 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INST TECHNOLOGY FOR SENSITIVE AND RELIABLE MUTATIONAL PROFILING IN PANCREATIC CANCER Complete
2012 R21 RFA-CA-12-002 CARTEGNI, LUCA SLOAN-KETTERING INST CAN RESEARCH CONTROLLED PREMATURE TERMINATION OF TRANSLATION TO GENERATE DESIGNATED TRUNCATED Complete
2016 R21 RFA-CA-15-002 CHANG, HSUEH-CHIA UNIVERSITY OF NOTRE DAME A SOLID-STATE NANOPORE MIRNA QUANTIFICATION TECHNOLOGY Complete
2019 R33 RFA-CA-18-003 KETTENBACH, ARMINJA NADINE DARTMOUTH COLLEGE Activity based profiling of Phosphoprotein phosphatases in cancer using mass spectrometry-based proteomics Complete
2000 R21 PAR-99-100 WEISSMAN, SHERMAN MORTON YALE UNIVERSITY DISPLAY METHODS FOR SURVEYING MUTATIONS Complete
2002 R21 PAR-99-102 MEHTA, ANAND S THOMAS JEFFERSON UNIVERSITY IDENTIFICATION OF SERUM GLYCOSYLATION MARKERS OF HCC Complete
2005 R21 RFA-CA-05-003 LIZARDI, PAUL M. YALE UNIVERSITY GLOBAL DNA METHYLATION PROFILES OF HEAD AND NECK CANCERS Complete
2008 R21 RFA-CA-07-035 KRON, STEPHEN J UNIVERSITY OF CHICAGO MALDI IMAGING OF CANCER SIGNALING SIGNATURES Complete
2011 R21 RFA-CA-10-005 DECAPRIO, ANTHONY P FLORIDA INTERNATIONAL UNIVERSITY PLATFORM FOR HIGH-THROUGHPUT ANALYSIS OF PROTEIN ADDUCTS FOR CARCINOGEN EXPOSURE Complete
2015 R21 RFA-CA-14-005 PENNO, MARGARET B JOHNS HOPKINS UNIVERSITY PEDIATRIC CANCER SALVIA BIOREPOSITORY Complete
2018 R33 RFA-CA-17-011 LU, JUN YALE UNIVERSITY CRISPR-based Enhanced Molecular Chipper Technology for Identifying Functional Noncoding Elements in Cancer Complete
1999 R43 PAR-98-066 TS'O, PAUL O. P. CCC DIAGNOSTICS, LLC ISOLATION AND PROFILING OF CIRCULATING PC CELLS IN BLOOD Complete
2001 R43 PAR-99-101 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS WHOLE GENOME METHYLATION ASSAY Complete

Pages